National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A national surveillance program of nosocomial blood stream infections (BSI) in the USA between April 1995 and June 1996 revealed that Candida was the fourth leading cause of nosocomial BSI, accounting for 8% of all infections. Forty-eight percent of 379 episodes of candidemia were due to species other than Candida albicans. The rank order of non-C. albicans species was C. glabrata (20%) > C. tropicalis (11%) > C. parapsilosis (8%) > C. krusei (5%) > other Candida spp. (4%). The species distribution varied according to geographic region, with non-C. albicans species predominating in the Northeast (54%) and Southeast (53%) regions, and C. albicans predominating in the Northwest (60%) and Southwest (70%) regions. In vitro susceptibility studies demonstrated that 95% of non-C. albicans isolates were susceptible to 5-fluorocytosine, and 84% and 75% were susceptible to fluconazole and itraconazole, respectively. Geographic variation in susceptibility to itraconazole, but not other agents, was observed. Isolates from the Northwest and Southeast regions were more frequently resistant to itraconazole (29-30%) than those from the Northeast and Southwest regions (17-18%). Molecular epidemiologic studies revealed possible nosocomial transmission (five medical centers). Continued surveillance for the presence of non-C. albicans species among hospitalized patients is recommended.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decreased susceptibility of C. krusei to amphotericin B (MIC90, 2 μg/ml) is consistent with previous reports for this organism (16, 26).”
In the citing paper
“C. glabrata and Candida krusei, which are known to be intrinsically resistant to fluconazole [23,24,26,27,28,29,30,31].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [23]
In the citing paper
“Although the susceptibility of Candida to the currently available antifungal agents can be predicted if the species of the infecting isolate is known (table 3) [1,4,6,[11][12][13][14][15][16][17][20][21][22][23][24], individual isolates do not necessarily follow the general pattern.”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [1]
In the citing paper
“Although Candida albicans remains the most common pathogen in oropharyngeal and cutaneous candidiasis, non-albicans species of Candida are increasingly associated with invasive candidiasis [1][2][3][4][5].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [1]
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109 · cited 1×
“Candida was noted to be the fourth most common cause of nosocomial blood stream infection (BSI), accounting for approximately 8% of all hospital-acquired BSI among medical centers surveyed by the Centers for Disease Control (CDC) (Banerjee et al. 1991; Emori and Gaynes 1993; Schaberg et al. 1991).”
BackgroundWingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Self-citationEpidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782 · cited 2×
“albicans may be increasing (Fridkin and Jarvis 1996; Pfaller 1996).”
BackgroundResultThe changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 7×
“albicans (Nguyen et al. 1996; Pfaller 1996; Rex et al. 1995; Wingard 1995).”
BackgroundInfluentialThe Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 4×
“parapsilosis were more likely to be related to the presence of an intravascular catheter and were not influenced by exposure to fluconazole or other antifungal agents (Abi-Said et al. 1997).”
BackgroundInfluentialImportance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542 · cited 1×
“albicans (Nguyen et al. 1996; Pfaller 1996; Rex et al. 1995; Wingard 1995).”
BackgroundNosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
Pfaller, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s89 · Cited by 502 · cited 3×
“albicans may be increasing (Fridkin and Jarvis 1996; Pfaller 1996).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Pfaller MA, Hollis RJ, Sader HS (1992) Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: Clinical Microbiology Procedures Handbook: Supplement 1. Ed, Isenberg HD. Washington, DC: ASM Press. pp. 10.5.c.1–10.6.3.
Cited by
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationGrowth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110
“Candidaemia and disseminated candidiasis are extremely serious medical conditions with mortality rates documented in different surveys of between 30–50%; some surveys have found them to be the second most common cause of death from nosocomial infection”
BackgroundPractice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Metadata
- Authors
- Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P.
- Affiliations
- University of Iowa (US)
- Virginia Commonwealth University (US)
- Corresponding author
- Pfaller, Michael A
- Venue
- Diagnostic Microbiology and Infectious Disease
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 30
- Issue
- 2
- Pages
- 121-129
- ISSN
- 0732-8893 (ISSN-L)
- OpenAlex
- W2004434620
- Cited by
- 424
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 15 · 2013: 7 · 2012: 19
- FWCI
- 21.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Diagnostic Microbiology and Infectious Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- non-albicans Candida, candidemia, nosocomial bloodstream infection, antifungal susceptibility, regional variation in resistance, itraconazole resistance, fluconazole susceptibility, 5-fluorocytosine, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, molecular epidemiology, nosocomial transmission, hospital infection surveillance
- MeSH terms
- Antifungal Agents, Candida, Candidiasis, Cross Infection, Drug Resistance, Microbial, Female, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program. https://app.cochat.ai/papers/10.1016/s0732-8893(97)00192-2
- The paper
- Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998). National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program. Diagnostic Microbiology and Infectious Disease. https://doi.org/10.1016/s0732-8893(97)00192-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.